Immunohistochemical investigation of new suppressor oncogene p130 in oral squamous cell carcinoma
- 15 March 1999
- journal article
- Published by Elsevier in Oral Oncology
- Vol. 35 (3) , 321-325
- https://doi.org/10.1016/s1368-8375(98)00089-x
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Expression of the retinoblastoma-related gene Rb2/p130 correlates with clinical outcome in endometrial cancer.Journal of Clinical Oncology, 1998
- Loss of RB and MTS1/CDKN2 (p16) expression in human sarcomasHuman Pathology, 1997
- A study of the localization of transferrin receptor in malignant tumor cellsMedical Molecular Morphology, 1995
- The Rb2/p130 gene product is a nuclear protein whose phosphorylation is cycle regulatedJournal of Cellular Biochemistry, 1995
- Expression of retinoblastoma gene (Rb) protein in T12MO prostatic adenocarcinomaZeitschrift für Krebsforschung und Klinische Onkologie, 1995
- The retinoblastoma protein and its relativesSeminars in Cancer Biology, 1995
- The adenovirus E1A-associated 130-kD protein is encoded by a member of the retinoblastoma gene family and physically interacts with cyclins A and E.Genes & Development, 1993
- Molecular cloning, chromosomal mapping, and expression of the cDNA for p107, a retinoblastoma gene product-related proteinCell, 1991
- Variant sublines with different metastatic potentials selected in nude mice from human oral squamous cell carcinomasJournal of Oral Pathology & Medicine, 1989
- A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcomaNature, 1986